Biotechnology has important implications for drug discovery and development, and the translation of the patented research results of the genomic era offers an opportunity to permanently revolutionise the way we develop drug technology. We are not seeing as much effective translation of drug targets as might be expected. This arlicle reports on the results of a study into collaborative strategies in Australian biotechnology, undertaken to assess their efficacy for enhancing the delivery of market-ready products. It supports earlier findings that formalised strategies such as patent pooling and clearinghouses currently provide little advantage, primarily because there is a high degree of fragmentation of the technology, and a low degree of fragmentation of the intellectual property landscape. Less structured arrangements continue to predominate, but it is questionable whether these models are currently being optimally utilised. This arlicle begins to consider the policy implications of encouraging particular models of co-operation in drug-based research.

Item Type:	Refereed Article
Keywords:	intellectual property, patenting, patent pools, drug discovery
Research Division:	Law and Legal Studies
Research Group:	Private law and civil obligations
Research Field:	Intellectual property law
Objective Division:	Law, Politics and Community Services
Objective Group:	Justice and the law
Objective Field:	Law reform
UTAS Author:	Nielsen, JL (Associate Professor Jane Nielsen)
UTAS Author:	Nicol, D (Professor Dianne Nicol)
UTAS Author:	Liddicoat, JE (Mr John Liddicoat)
ID Code:	97004
Year Published:	2014
Funding Support:	Australian Research Council (DP0985077)
Deposited By:	Faculty of Law
Deposited On:	2014-11-28
Last Modified:	2018-06-26
Downloads:	0